Hacker News Reader

Accountability seems to be slower in the pharma industry, but it did come for Theranos and Purdue. There doesn't seem to be the same kind of safety issue, only horrific pricing issues and a complicated supply problem for certain kinds of medications.

View on HN

I don’t see how we can say that pharmaceuticals don’t have serious safety issues.

Consider Vioxx:

> Merck withdrew the drug after disclosures that it withheld information about rofecoxib's risks from doctors and patients for over five years, allegedly resulting in between 88,000 and 140,000 cases of serious heart disease.

Vioxx is fine. Just improper disclosures. Many patients who it was right for lost out because of the withdrawal

Noting though that barring extreme cases, a safety issue with a batch of drugs would be really hard to detect.

Reply on news.ycombinator.com